NIH Director’s Message on Pain Awareness Month – New Funding Opportunities

NIH Director, Dr. Francis Collins, released a Director’s Statement on Pain Awareness Month and National Recovery Month, and the recently declared Prescription Opioid and Heroin Epidemic Awareness Week (Sep. 17-23). Within this statement, you will see reference to the 3 newly published NINDS RFAs, outlined below:

• Analytical and/or Clinical Validation of a Candidate Biomarker for Pain (R61/R33 Clinical Trial Optional) RFA-NS-18-046
• Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed) RFA-NS-18-043
• Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R21 Clinical Trial Not Allowed) RFA-NS-18-042

View the complete list of NIH HEAL Initiative Funding Announcements and Opportunities